New Issue: RBC prices $2.7 million bullish barrier enhanced notes on five stocks

By Marisa Wong

Morgantown, W.Va., Oct. 23 – Royal Bank of Canada priced $2.7 million of 0% bullish barrier enhanced return notes due Oct. 25, 2018 linked to a basket of stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The basket is comprised of the common stocks of Amgen Inc., Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc. and Pfizer Inc.

The payout at maturity will be par plus 150% of any basket gain, up to a maximum return of 43%. If the basket falls by 25% or less, the payout will be par. If the basket declines by more than 25%, investors will be fully exposed to the loss.

RBC Capital Markets, LLC is the underwriter.

Issuer:	Royal Bank of Canada
Issue:	Bullish barrier enhanced return notes
Underlying stocks:	Amgen Inc., Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc. and Pfizer Inc.
Amount:	$2.7 million
Maturity:	Oct. 25, 2018
Coupon:	0%
Price:	Par
Payout at maturity:	Par plus 150% of any basket gain, up to 43% maximum return; if basket falls by 25% or less, par; if basket declines by more than 25%, full exposure to decline
Pricing date:	Oct. 21
Settlement date:	Oct. 26
Underwriter:	RBC Capital Markets, LLC
Fees:	2.75%
Cusip:	78012KHX8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.